62. Outcomes of Density-Targeted Supplemental Breast Magnetic Resonance Imaging Screening by Breast Cancer Risk: Long-Term Health and Economic Considerations.
作者: Anna N A Tosteson.;Natasha K Stout.;Yu-Ru Su.;Nicolien T van Ravesteyn.;Kathryn P Lowry.;Linn Abraham.;Oguzhan Alagoz.;Roberta DiFlorio-Alexander.;Harry J de Koning.;John M Hampton.;Louise Henderson.;Jeanne S Mandelblatt.;Tracy Onega.;Clyde B Schechter.;Brian L Sprague.;Sarah Stein.;Amy Trentham-Dietz.;Diana L Miglioretti.;Karla Kerlikowske.;Christoph I Lee.
来源: Ann Intern Med. 2026年
Federally mandated breast density notifications motivate consideration of supplemental breast magnetic resonance imaging (MRI).
64. Efficacy, Comparative Effectiveness, and Harm of Respiratory Syncytial Virus Vaccines in Adults Who Are Not Pregnant or Immunocompromised: A Rapid Review for the American College of Physicians.
作者: Isabel T K Moser.;Andreea I Dobrescu.;Isolde Sommer.;Stella Goeschl.;Amin Sharifan.;Dominic Ledinger.;Irma Klerings.;Gerald Gartlehner.
来源: Ann Intern Med. 2026年
Respiratory syncytial virus (RSV) causes respiratory disease with a high disease burden in older adults and people with comorbid conditions.
66. In older adults, high- vs. standard-dose influenza vaccine reduced hospitalization for influenza or pneumonia in those with CKD.
GIM/FP/GP: [Formula: see text] Geriatrics: [Formula: see text] Nephrology: [Formula: see text].
67. In adults with prediabetes and overweight or obesity, an AI- vs. human-led lifestyle intervention was noninferior for a composite outcome at 12 mo.
GIM/FP/GP: [Formula: see text] Endocrinology: [Formula: see text] Public Health: [Formula: see text].
69. In severe pneumonia or ARDS, low-dose, short-course corticosteroids vs. placebo or usual care reduce short-term mortality.
GIM/FP/GP: [Formula: see text] Infectious Disease: [Formula: see text] Critical Care: [Formula: see text] Pulmonology: [Formula: see text].
70. In adults at high CV risk and without previous MI or stroke, evolocumab reduced major adverse CV event composites at a median 4.6 y.
GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text].
71. After cardioversion in AF, continued caffeinated coffee consumption vs. abstinence reduced AF or atrial flutter recurrence at 6 mo.
GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text].
72. Nicotine e-cigarettes increase smoking cessation more than nicotine replacement therapy or non-nicotine e-cigarettes at ≥6 mo.
GIM/FP/GP: [Formula: see text] Public Health: [Formula: see text].
73. After successful catheter ablation for AF, rivaroxaban did not reduce a composite of stroke or systemic embolism vs. aspirin at 36 mo.
GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text] Hematology: [Formula: see text].
74. In healthy adults, a modified RNA vs. inactivated influenza vaccine reduced laboratory-confirmed influenza-like illness at ≥14 d.
GIM/FP/GP: [Formula: see text] Infectious Disease: [Formula: see text] Public Health: [Formula: see text].
75. In adults with severe metabolic acidosis and moderate to severe AKI, IV sodium bicarbonate did not reduce mortality at 90 d.
GIM/FP/GP: [Formula: see text] Critical Care: [Formula: see text] Nephrology: [Formula: see text].
76. Stable Supportive Footwear for Self-managing Hip Osteoarthritis Pain : A Randomized Clinical Trial.
作者: Kade L Paterson.;Kim L Bennell.;Ben R Metcalf.;Fiona McManus.;Karen E Lamb.;Jesse Pardo.;Sarah Jones.;Rana S Hinman.
来源: Ann Intern Med. 2026年
Few effective nonsurgical treatments exist for hip osteoarthritis. Footwear influences hip forces and may be a promising novel approach.
79. COVID-19 Vaccines for 2025-2026 in Adults Who Are Not Pregnant or Immunocompromised: Rapid Practice Points From the American College of Physicians.
作者: Amir Qaseem.;Adam J Obley.;Curtis S Harrod.;Timothy J Wilt.;Kate Carroll.;Linda L Humphrey.; .;Linda L Humphrey.;Adam J Obley.;Ray Haeme.;Alysa Krain.;Thejaswi Poonacha.;Sameer D Saini.;Timothy J Wilt.;Kate Carroll.;Curtis S Harrod.;Amir Qaseem.;Chelsea Vigna.
来源: Ann Intern Med. 2026年
The American College of Physicians (ACP) developed these rapid practice points addressing the effectiveness, comparative effectiveness, and harms of Omicron-adapted COVID-19 vaccines in adults (aged ≥18 years) who are not pregnant or immunocompromised.
|